Indications |
Oral Adjunct to levodopa treatment in Parkinson's disease Adult: 200 mg with each levodopa/dopa decarboxylase inhibitor dose. Max: 200 mg 10 times daily. |
Contraindications |
History of neuroleptic malignant syndrome and nontraumatic rhabdomyolysis. Phaeochromocytoma. Hepatic impairment. |
Warnings / Precautions |
Levodopa-induced orthostatic hypotension may be aggravated. Abrupt withdrawal. Concomitant use with a selective MAO-A and MAO-B inhibitor, or concomitant use with a selective MAO-A plus a selective MAO-B inhibitor. Biliary obstruction. Impairs ability to drive and operate machinery. Pregnancy and lactation. Children and elderly. |
Adverse Reactions |
Dyskinesia, GI symptoms, reddish brown urine discoloration, fatigue, insomnia, paroniria, confusion, hallucinations, dizziness, orthostatic/postural hypotension, vertigo, headache, leg cramps, hyperkinesia, tremor and increased sweating. |
Drug Interactions |
Drugs metabolised by COMT e.g. adrenaline, apomorphine, dobutamine, dopamine, isoprenaline, methyldopa, noradrenaline and remiterol. Iron preparations and levodopa. Avoid ethanol. See Below for More entacapone Drug Interactions |
Lab Interactions |
Slight decrease in Hb, erythrocyte count and haematocrit. Increases in liver enzymes. |
Food Interactions |
Avoid ethanol. |
Mechanism of Actions |
Entacapone is a selective, reversible, peripheral inhibitor of COMT, an enzyme involved in the metabolism of dopamine and levodopa. It is used in patients with Parkinson's disease and "end-of-dose" motor fluctuations that cannot be stabilised on levodopa combinations alone. Absorption: Plasma concentrations peak about 1 hr after oral doses. Bioavailability: About 35%. Distribution: 98% bound to plasma proteins. Excretion: Mainly excreted in the faeces; about 10-20% being excreted in the urine, mainly as glucuronide conjugates. |
Administration |
May be taken with or without food. |
ATC Classification |
N04BX02 - entacapone ; Belongs to the class of other dopaminergic agents used in the management of Parkinson's disease. |
Available As |
|
Entacapone
Post Review about Entacapone Click here to cancel reply.
Entacapone Containing Brands
Entacapone is used in following diseases
Drug - Drug Interactions of Entacapone
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.